Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trinity Biotech PLC (NASDAQ:TRIB)

5.12
Delayed Data
As of Oct 19
 -0.12 / -2.29%
Today’s Change
5.09
Today|||52-Week Range
7.40
-26.01%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$126.0M

Company Description

Trinity Biotech Plc develops, manufactures and markets diagnostic test kits for the clinical laboratory and Point-of-Care segments of the diagnostic market. Its products are used to detect infectious diseases, sexually transmitted diseases, blood disorders and autoimmune disorders, as well as monitoring and diagnosing diabetes and haemoglobin variants. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Contact Information

Trinity Biotech Plc
IDA Business Park
Bray Wicklow 10
P:(531) 276-9800
Investor Relations:

Employees

Shareholders

Other institutional46.01%
Mutual fund holders17.21%
Individual stakeholders--

Top Executives

Ronan O'CaoimhChairman & Chief Executive Officer
Kevin TansleyCFO, Secretary & Executive Director
Jim WalshExecutive Director & Chief Scientific Officer